BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1313 related articles for article (PubMed ID: 19236618)

  • 1. Anxiety and depression symptoms in patients with diabetes.
    Collins MM; Corcoran P; Perry IJ
    Diabet Med; 2009 Feb; 26(2):153-61. PubMed ID: 19236618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive and anxiety symptoms in screening for clinical depression in diabetes: a systematic examination of diagnostic performances of the HADS and BDI-SF.
    Sultan S; Luminet O; Hartemann A
    J Affect Disord; 2010 Jun; 123(1-3):332-6. PubMed ID: 19861228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and psychosocial factors of anxiety and depression in breast cancer patients.
    Lueboonthavatchai P
    J Med Assoc Thai; 2007 Oct; 90(10):2164-74. PubMed ID: 18041438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Affective and anxiety disorders in a German sample of diabetic patients: prevalence, comorbidity and risk factors.
    Hermanns N; Kulzer B; Krichbaum M; Kubiak T; Haak T
    Diabet Med; 2005 Mar; 22(3):293-300. PubMed ID: 15717877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of the Hospital Anxiety and Depression Scale (HADS) in patients with chronic obstructive pulmonary disease: a pilot study.
    Dowson C; Laing R; Barraclough R; Town I; Mulder R; Norris K; Drennan C
    N Z Med J; 2001 Oct; 114(1141):447-9. PubMed ID: 11700772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of depression and anxiety in onset of diabetes in a large population-based study.
    Engum A
    J Psychosom Res; 2007 Jan; 62(1):31-8. PubMed ID: 17188118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and predictors of unexplained neurological symptoms in an academic neurology outpatient clinic--an observational study.
    Snijders TJ; de Leeuw FE; Klumpers UM; Kappelle LJ; van Gijn J
    J Neurol; 2004 Jan; 251(1):66-71. PubMed ID: 14999491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and risk factors for depression in non-demented primary care attenders aged 75 years and older.
    Weyerer S; Eifflaender-Gorfer S; Köhler L; Jessen F; Maier W; Fuchs A; Pentzek M; Kaduszkiewicz H; Bachmann C; Angermeyer MC; Luppa M; Wiese B; Mösch E; Bickel H;
    J Affect Disord; 2008 Dec; 111(2-3):153-63. PubMed ID: 18372049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between anxiety, depression, and somatic symptoms in a large population: the HUNT-II study.
    Haug TT; Mykletun A; Dahl AA
    Psychosom Med; 2004; 66(6):845-51. PubMed ID: 15564348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for anxiety and depression after stroke: comparison of the hospital anxiety and depression scale and the Montgomery and Asberg depression rating scale.
    Sagen U; Vik TG; Moum T; Mørland T; Finset A; Dammen T
    J Psychosom Res; 2009 Oct; 67(4):325-32. PubMed ID: 19773025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal symptoms in primary care: prevalence and association with depression and anxiety.
    Mussell M; Kroenke K; Spitzer RL; Williams JB; Herzog W; Löwe B
    J Psychosom Res; 2008 Jun; 64(6):605-12. PubMed ID: 18501261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Socio-economic inequalities in the prevalence of Type 2 diabetes, cardiovascular risk factors and chronic diabetic complications in the Basque Country, Spain.
    Larrañaga I; Arteagoitia JM; Rodriguez JL; Gonzalez F; Esnaola S; Piniés JA;
    Diabet Med; 2005 Aug; 22(8):1047-53. PubMed ID: 16026371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The burden of lower urinary tract symptoms: evaluating the effect of LUTS on health-related quality of life, anxiety and depression: EpiLUTS.
    Coyne KS; Wein AJ; Tubaro A; Sexton CC; Thompson CL; Kopp ZS; Aiyer LP
    BJU Int; 2009 Apr; 103 Suppl 3():4-11. PubMed ID: 19302497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of depression and anxiety symptoms in elderly patients admitted in post-acute intermediate care.
    Yohannes AM; Baldwin RC; Connolly MJ
    Int J Geriatr Psychiatry; 2008 Nov; 23(11):1141-7. PubMed ID: 18457336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the Hospital Anxiety and Depression Scale for use with multiple sclerosis patients.
    Honarmand K; Feinstein A
    Mult Scler; 2009 Dec; 15(12):1518-24. PubMed ID: 19965520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychotherapy intervention to reduce depressive symptoms in patients with diabetic foot syndrome.
    Simson U; Nawarotzky U; Friese G; Porck W; Schottenfeld-Naor Y; Hahn S; Scherbaum WA; Kruse J
    Diabet Med; 2008 Feb; 25(2):206-12. PubMed ID: 18290863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and correlates of depressive disorders in elderly with type 2 diabetes in primary health care settings.
    Shehatah A; Rabie MA; Al-Shahry A
    J Affect Disord; 2010 Jun; 123(1-3):197-201. PubMed ID: 19804911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between cod liver oil use and symptoms of depression: the Hordaland Health Study.
    Raeder MB; Steen VM; Vollset SE; Bjelland I
    J Affect Disord; 2007 Aug; 101(1-3):245-9. PubMed ID: 17184843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validity of the Hospital Anxiety and Depression Scale to assess depression and anxiety following traumatic brain injury as compared with the Structured Clinical Interview for DSM-IV.
    Whelan-Goodinson R; Ponsford J; Schönberger M
    J Affect Disord; 2009 Apr; 114(1-3):94-102. PubMed ID: 18656266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anxiety disorders in adults treated by hemodialysis: a single-center study.
    Cukor D; Coplan J; Brown C; Friedman S; Newville H; Safier M; Spielman LA; Peterson RA; Kimmel PL
    Am J Kidney Dis; 2008 Jul; 52(1):128-36. PubMed ID: 18440682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 66.